News

b

b

Current News in Drug Discovery

RSS Nature Reviews Drug Discovery
  • Quantitative systems toxicology: modelling to mechanistically understand and predict drug safety October 27, 2025
    Nature Reviews Drug Discovery, Published online: 27 October 2025; doi:10.1038/s41573-025-01308-zQuantitative systems toxicology (QST) models have the potential to increase confidence in the safety assessment of drug candidates and to inform project progression decisions. This article overviews the fundamentals of constructing and using QST models, presents the state-of-the-art for models of cardiovascular, gastrointestinal, hepatic and renal […]
    Christopher E. Goldring
  • Trends in gene therapy delivery technologies October 23, 2025
    Nature Reviews Drug Discovery, Published online: 23 October 2025; doi:10.1038/d41573-025-00171-2Trends in gene therapy delivery technologies
    Emily Capra
  • Designing error-free prime editors October 22, 2025
    Nature Reviews Drug Discovery, Published online: 22 October 2025; doi:10.1038/d41573-025-00172-1Designing error-free prime editors
    Sarah Crunkhorn
  • Embracing the avoid-ome October 15, 2025
    Nature Reviews Drug Discovery, Published online: 15 October 2025; doi:10.1038/d41573-025-00169-wPatrick Walters, the chief scientist of OpenADMET, discusses an ambitious open-science project aimed at figuring out how to avoid pharmacokinetic and toxicity traps in small-molecule drug discovery.
    Asher Mullard
  • FDA new drug approvals in Q3 2025 October 13, 2025
    Nature Reviews Drug Discovery, Published online: 13 October 2025; doi:10.1038/d41573-025-00170-3FDA new drug approvals in Q3 2025
    Paul Verdin
  • Innovation in medicines for global health: a 20-year landscape analysis October 13, 2025
    Nature Reviews Drug Discovery, Published online: 13 October 2025; doi:10.1038/d41573-025-00164-1Innovation in medicines for global health: a 20-year landscape analysis
    Paul Ashigbie
  • Cancer cachexia contender enters first pivotal trial October 10, 2025
    Nature Reviews Drug Discovery, Published online: 10 October 2025; doi:10.1038/d41573-025-00168-xCan Pfizer’s GDF15-blocking, appetite-boosting antibody ponsegromab address a cancer-induced wasting syndrome — and help patients live longer in the process?
    Asher Mullard
  • Genmab nabs EGFR × LGR5 bispecific in US$8 billion Merus acquisition October 8, 2025
    Nature Reviews Drug Discovery, Published online: 08 October 2025; doi:10.1038/d41573-025-00166-zGenmab nabs EGFR × LGR5 bispecific in US$8 billion Merus acquisition
    Asher Mullard

Vitreon America™ Launches Botanicopeia™ Database and Federal Government Services at NIH Festival+

 BETHESDA, MD, September 17, 2016 − Vitreon America, Inc.™ participated this week in the National Institute of Health (NIH) Intramural Research Program’s 30th Annual NIH Research Festival which was held September 15-16, 2016 at the NIH Bethesda, Maryland campus.

The Festival included plenary sessions, symposia, exhibits, poster sessions and tours designed to encourage sharing and learning about the exciting research taking place on NIH campus.

Vitreon America™ was selected by the Technical Sales Association (TSA) which sponsors the Research Festival Exhibit, to launch its state-of-the-art Phytochemical and Ethnobotanical database subscription services, Botanicopeia™.

Attending on behalf of Vitreon America™
were Michael Megginson, VP of Business Development (left) and Jorgen Sandberg,
CEO (right).

Vitreon America was pleased to see the interest from the NIH Institutions to utilize the Botanicopeia™ database subscriptions with many NIH researchers expressing interest in considering the Vitreon America Botanical Research Analytic services as well to optimize the Botanicopeia™ database.

Based on the NIH researchers feedback, Vitreon America has established a Botanicopeia™ database subscription service agreement and subscription service with botanical research analytic services through Marshall Communications Corporation, www.marshallcomm.com.

Vitreon America services are available through Marshall Communications Corporation (VOSB) on NIH’s Information Technology Acquisition and Assessment Center’s (NITAAC)- Government-wide Acquisition Contract (GWAC) vehicle. [Prime Contract Holder #HHSN316201500063W]

Vitreon America™ was established with the goal of commercializing their Botanicopeia™ database and botanical research analytic services for development of botanicals and phytochemicals in the creation of new medicinal products by Vitreon America Clients.

To find out more about our Services please contact us for assistance at 1-888-214-2584 or at info@vitreonamerica.com

About Vitreon America™

Vitreon AmericaTM was formed with the goal of disseminating their BotanicopeiaTM database to encourage the increased use of botanicals and phytochemicals in the creation of new medicines.

Contact Vitreon America, Inc.

Vitreon America Botanical Research Center @ Hopkins Johns Hopkins University

MCC 9601 Medical Center Drive, Suite 221
Rockville, Maryland 20850

+1-888-214-2584

j.shaver@advasur.com